Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EDCTP approves € 80 M of funding to boost HIV/AIDS, TB and malaria research

04.06.2008
The European & Developing Countries Clinical Trials Partnership (EDCTP) has approved over € 80 million for research into prevention of HIV/AIDS, tuberculosis and malaria in Africa. This sum is the highest amount of EDCTP funding approved to date. The approval marks an increase of European investment in research into the three poverty-related diseases and is expected to significantly enhance cooperation between European and African researchers.

EDCTP is a partnership of 14 European Member States plus Norway, Switzerland and sub-Saharan countries. The Partnership aims to reduce the global burden of HIV/AIDS, TB and malaria by pooling resources for conducting clinical trials in sub-Saharan Africa. The current approval of funding consists of a contribution from the European Commission of € 40 M, to be matched by European Member States and third parties. The projects involve 12 European countries and 22 sub-Saharan African countries. Funding was approved in the following areas:

Tuberculosis Vaccines
Malaria Treatment
Malaria in Pregnancy
Malaria Vaccines
Ethics review capacity
WHO regulatory affairs
Networks of Excellence
Senior Fellowships
Additional funding in the areas of HIV treatment, vaccines and microbicides, TB treatment and Networks of Excellence is expected to be approved in the second half of 2008.

The projects on TB and malaria that will be funded combine clinical trials with capacity building and networking activities. By integrating these activities EDCTP aims to enhance sustainability of conducting clinical trials on the African continent. A number of projects focuses on creating and developing capacity for ethics review of clinical trials and of enhancing the regulatory framework needed for approval of medicines in Africa. This enables African countries to conduct high-quality and ethically sound clinical trials, and to assess the safety and efficacy of all medicines that enter the African market.

EU Member State commitment and African leadership very encouraging
European Science and Research Commissioner Janez Potocnik underlined the integration of policies achieved by the partnership: "This decision from the EDCTP General Assembly shows the commitment of the participating countries and the European Commission in the fight against the three main poverty-related diseases in and for Africa. We're confident that our cooperation with African researchers will make a difference".

Prof. Charles Mgone, EDCTP’s executive director expressed the significance of the approval when he said: “This is a very significant milestone for collaboration between north and south in the fight against the three main diseases of poverty namely HIV/AIDS, tuberculosis and malaria. It is also very gratifying to note that among the 26 projects approved for funding 22 have African scientists based in Africa as their principal investigators. This underscores EDCTP’s objective of fostering a genuine partnership and enhancing clinical research capacity in Africa.”

About EDCTP
EDCTP aims through research integration to accelerate the development of new or improved drugs, vaccines, diagnostics and microbicides against HIV/AIDS, malaria and tuberculosis, with a focus on phase II and III clinical trials in sub-Saharan Africa.

EDCTP supports integrated multicentre projects which combine clinical trials, capacity building and networking. The aim of integrating these three activities is to develop the capacity to conduct clinical trials in sub-Saharan Africa in a sustainable way.

The basis of EDCTP is partnership. It unites 14 participating European Union (EU) Member States plus Norway and Switzerland with sub-Saharan African countries. The partnership helps EU Member States to integrate and coordinate their own national research and development programmes and form partnerships with their African counterparts.

Ilona van den Brink | alfa
Further information:
http://ec.europa.eu/research/index.cfm
http://www.edctp.org/index.php?id=428

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Research reveals how order first appears in liquid crystals

23.05.2018 | Life Sciences

Space-like gravity weakens biochemical signals in muscle formation

23.05.2018 | Life Sciences

NIST puts the optical microscope under the microscope to achieve atomic accuracy

23.05.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>